Qube Research & Technologies LTD Beam Therapeutics Inc. Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 70,431 shares of BEAM stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,431
Previous 593,815
88.14%
Holding current value
$1.55 Million
Previous $10.1 Million
83.08%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding BEAM
# of Institutions
249Shares Held
95MCall Options Held
888KPut Options Held
549K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$243 Million1.88% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.1MShares$222 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$168 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$106 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.55B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...